TCRSEQ

Serial Number 87891560
602

Registration Progress

Application Filed
Apr 24, 2018
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: TCRSEQ
Previous Owner: Adaptive Biotechnologies
Classes: 042

Trademark Image

TCRSEQ

Basic Information

Serial Number
87891560
Filing Date
April 24, 2018
Abandonment Date
February 22, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 1, 2019
Classes
042

Rights Holder

Adaptive Biotechnologies

03
Address
Suite 200
1551 Eastlake Avenue East
Seattle, WA 98102

Ownership History

Adaptive Biotechnologies

Original Applicant
03
Seattle, WA

Legal Representation

Attorney
Stacy Taylor

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Apr 1, 2019 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Apr 1, 2019 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 21, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 21, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 21, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 14, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 3, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 27, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of new technology for others in the field of biotechnology; DNA analysis services; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of genetics and genetic engineering
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042